{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:49:58Z","timestamp":1790272198897,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ymgme.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T02:34:41Z","timestamp":1595644481000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses"],"prefix":"10.1016","volume":"131","author":[{"given":"Ainslie","family":"Derrick-Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Kaidonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Chin","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoDan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.07.006_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0010","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I","volume":"7","author":"Wilkinson","year":"2012","journal-title":"IIIA and IIIB PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1471-4159.1978.tb12388.x","article-title":"Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls","volume":"30","author":"Constantopoulos","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-4159.1980.tb11220.x","article-title":"Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues","volume":"34","author":"Constantopoulos","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.1994.62051852.x","article-title":"Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases Correlates with abnormal accumulation of GM2 ganglioside","volume":"62","author":"Siegel","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0040","first-page":"433","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders Semin","volume":"15","author":"Walkley","year":"2004","journal-title":"Cell Dev Biol"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0045","series-title":"Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice Diseases 5","author":"Derrick-Roberts","year":"2017"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2016.04.002","article-title":"N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice","volume":"118","author":"Kaidonis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2015.11.013","article-title":"Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder","volume":"278","author":"King","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-017-0044-4","article-title":"A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome","volume":"40","author":"Lau","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jgm.2816","article-title":"Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery","volume":"16","author":"McIntyre","year":"2014","journal-title":"J Gene Med"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymgme.2019.05.005","article-title":"Evaluation of biomarkers for Sanfilippo syndrome","volume":"128","author":"Saville","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/hum.2013.141","article-title":"Lentiviral-mediated gene therapy results in sustained expression of beta-glucuronidase for up to 12 months in the gus(mps\/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII","volume":"25","author":"Derrick-Roberts","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.ymgme.2020.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00216-016-0076-x","article-title":"Multimodal Detection of GM2 and GM3 Lipid Species in the Brain of Mucopolysaccharidosis Type II Mouse by Serial Imaging Mass Spectrometry and Immunohistochemistry","volume":"409","author":"Dufresne","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brainresbull.2007.07.018","article-title":"Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy","volume":"74","author":"Garcia-Rivera","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"Pan","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2006.01.008","article-title":"Long-term memory for aversive training is impaired in Idua(\u2212\/\u2212) mice, a genetic model of mucopolysaccharidosis type I","volume":"1076","author":"Reolon","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.05.079","article-title":"Characterization of a C57BL\/6 congenic mouse strain of mucopolysaccharidosis type IIIA","volume":"1104","author":"Crawley","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2004.08.019","article-title":"Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA)","volume":"158","author":"Hemsley","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","article-title":"Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice","volume":"90","author":"Hemsley","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025717","article-title":"Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test","volume":"6","author":"Langford-Smith","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","article-title":"Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA","volume":"92","author":"Roberts","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ymgme.2010.08.013","article-title":"Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII","volume":"101","author":"Bielicki","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0135","series-title":"Behavioural abnormalities in a murine model of a human lysosomal storage disease Neuroreport","first-page":"507","volume":"4","author":"Chang","year":"1993"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2012.03.022","article-title":"Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII","volume":"106","author":"Macsai","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172435","article-title":"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II","volume":"12","author":"Gleitz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.21682","article-title":"Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA","volume":"219","author":"Roberts","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-4159.1980.tb12515.x","article-title":"The use of Sep-Pak C18 cartridges during the isolation of gangliosides","volume":"35","author":"Williams","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymgme.2016.09.003","article-title":"Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy","volume":"119","author":"Derrick-Roberts","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","article-title":"Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA","volume":"60","author":"Roberts","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.1998.tb02745.x","article-title":"Murine MPS I: insights into the pathogenesis of Hurler syndrome","volume":"53","author":"Russell","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/glycob\/11.1.99","article-title":"A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant","volume":"11","author":"Bhattacharyya","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0195","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood.V78.11.3081.3081","article-title":"Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation","volume":"78","author":"Birkenmeier","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0200","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns\u2212\/\u2212) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0205","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1016\/S0021-9258(19)50023-0","article-title":"Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate","volume":"267","author":"Turnbull","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Montano","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/bj1520057","article-title":"Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro","volume":"152","author":"Avila","year":"1975","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s004010050562","article-title":"Neuropathology of murine mucopolysaccharidosis type VII Acta","volume":"92","author":"Levy","year":"1996","journal-title":"Neuropathol"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(76)90245-6","article-title":"Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease","volume":"116","author":"Purpura","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0230","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","article-title":"Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons","volume":"10","author":"Walkley","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ymgme.2020.07.006_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2018.04.014","article-title":"Delayed development of ossification centers in the tibia of prenatal and early postnatal MPS VII mice","volume":"124","author":"Jiang","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2015.12.012","article-title":"Selective normalisation of regional brain bis(monoacylglycero)phosphate in the mucopolysaccharidosis 1 (Hurler) mouse","volume":"277","author":"Saville","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2011.01.015","article-title":"Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment","volume":"103","author":"Arfi","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2019.08.008","article-title":"Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA","volume":"129","author":"Saville","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.expneurol.2015.12.012","article-title":"Selective normalisation of regional brain bis(monoacylglycero)phosphate in the mucopolysaccharidosis 1 (Hurler) mouse","volume":"277","author":"Saville","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2017.09.006","article-title":"Quantitative neuroimaging in mucopolysaccharidoses clinical trials","volume":"122S","author":"Nestrasil","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.07.006_bb0265","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1148\/rg.2016150168","article-title":"Neuroimaging Findings in Patients with Mucopolysaccharidosis: What You Really Need to Know","volume":"36","author":"Reichert","year":"2016","journal-title":"Radiographics"}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2021.12.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922030175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922030175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:40:56Z","timestamp":1723318856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922030175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S109671922030175X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.07.006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ymgme.2021.12.011","asserted-by":"object"}]},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}